Yoshito Tsushima Selected Research

Pheochromocytoma

3/2022	An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
7/2011	Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma.
6/2008	Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshito Tsushima Research Topics

Disease

66	Neoplasms (Cancer) 03/2023 - 07/2003
10	Hemorrhage 02/2024 - 01/2003
7	Squamous Cell Carcinoma of Head and Neck 08/2021 - 06/2013
6	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 12/2007
6	Rheumatoid Arthritis 01/2021 - 11/2014
6	Body Weight (Weight, Body) 11/2018 - 09/2003
5	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 02/2014
4	Liver Failure 01/2023 - 01/2020
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2014
4	Renal Insufficiency (Renal Failure) 01/2021 - 02/2016
4	Neoplasm Metastasis (Metastasis) 01/2016 - 06/2008
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2024 - 01/2018
3	Placenta Previa 02/2024 - 10/2019
3	Anaphylaxis (Anaphylactic Shock) 09/2023 - 01/2023
3	Pheochromocytoma 03/2022 - 06/2008
3	Thyroid Neoplasms (Thyroid Cancer) 02/2022 - 03/2018
3	Diabetes Mellitus 07/2021 - 08/2017
3	Triple Negative Breast Neoplasms 04/2021 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 11/2018
3	Lung Neoplasms (Lung Cancer) 01/2020 - 09/2003
3	Osteoid Osteoma 11/2018 - 01/2012
3	Adenoma (Adenomas) 07/2017 - 01/2014
3	Hematoma 02/2014 - 01/2013
2	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2020
2	Cicatrix (Scar) 09/2022 - 08/2018
2	Lymphoma (Lymphomas) 08/2022 - 11/2017
2	Thrombosis (Thrombus) 03/2022 - 11/2020
2	Paraganglioma (Paragangliomas) 03/2022 - 06/2008
2	Hypertrophy 01/2022 - 01/2018
2	Cognitive Dysfunction 01/2022 - 01/2019
2	Hypoxia (Hypoxemia) 03/2021 - 01/2018
2	Nephrogenic Fibrosing Dermopathy 01/2021 - 02/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 11/2020
2	Inflammation (Inflammations) 01/2021 - 07/2015
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2021
2	Heart Failure 01/2018 - 02/2016
2	Lymphatic Metastasis 01/2018 - 06/2008
2	Glioma (Gliomas) 12/2017 - 01/2015
2	Insulin Resistance 12/2017 - 01/2014
2	Hemothorax 01/2016 - 11/2009
2	Rupture 01/2016 - 02/2014

Drug/Important Bio-Agent (IBA)

23	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024 - 07/2003
15	Amino Acids FDA Link 11/2020 - 05/2013
14	Contrast MediaIBA 09/2023 - 07/2003
11	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 03/2007
7	IodineIBA 07/2021 - 09/2003
7	Amino Acid Transport Systems (Amino Acid Transporter)IBA 11/2020 - 05/2013
7	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 05/2013
7	Deoxyglucose (2 Deoxy D glucose)IBA 01/2016 - 02/2007
6	Therapeutic UsesIBA 01/2022 - 03/2014
5	GadoliniumIBA 09/2023 - 02/2016
5	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021 - 01/2008
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2015
4	gadolinium ethoxybenzyl DTPA FDA Link 11/2021 - 01/2020
4	gadodiamide (Omniscan)FDA Link 01/2021 - 10/2016
4	Radioisotopes (Radionuclides)IBA 11/2020 - 01/2016
4	Fluorine-18IBA 11/2018 - 09/2003
4	Adenosine Triphosphate (ATP)IBA 01/2018 - 07/2004
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 01/2014
3	3-Iodobenzylguanidine (Iobenguane)IBA 03/2022 - 06/2008
3	Bevacizumab (Avastin)FDA Link 04/2021 - 04/2014
3	RadiopharmaceuticalsIBA 03/2021 - 02/2018
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 12/2014
3	HexokinaseIBA 01/2021 - 01/2008
3	phenylalanine methyl esterIBA 05/2020 - 05/2015
3	EnbucrilateIBA 09/2016 - 01/2016
2	Epinephrine (Adrenaline)FDA LinkGeneric 09/2023 - 06/2015
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2023 - 01/2020
2	B7-H1 AntigenIBA 09/2021 - 06/2019
2	Cetuximab (Erbitux)FDA Link 08/2021 - 10/2019
2	CreatinineIBA 07/2021 - 08/2017
2	AvidinIBA 04/2021 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
2	technetium tc-99m tetrofosmin (Myoview)FDA Link 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2020
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2020 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 10/2019 - 01/2018
2	Keratins (Keratin)IBA 03/2019 - 06/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 04/2014
2	Indium-111IBA 01/2018 - 03/2014
2	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 10/2016 - 10/2016

Therapy/Procedure

16	Therapeutics 05/2022 - 12/2007
4	Hysterectomy 02/2024 - 01/2014
4	Radiofrequency Ablation 03/2023 - 12/2007
4	Hepatectomy 01/2023 - 01/2020
4	Catheters 03/2022 - 11/2011
4	Cryosurgery 11/2021 - 11/2015
4	Punctures 11/2021 - 11/2009
3	Length of Stay 02/2024 - 10/2019
3	Cesarean Section (Caesarean Section) 02/2024 - 10/2019
3	Adrenalectomy 09/2022 - 01/2014
3	Radioimmunotherapy 04/2021 - 11/2017
2	Premedication 07/2023 - 10/2014
2	Heavy Ion Radiotherapy 11/2021 - 01/2020
2	Blood Transfusion (Blood Transfusions) 07/2021 - 01/2014
2	Injections 01/2021 - 04/2009
2	Biological Therapy 01/2021 - 09/2017
2	Uterine Artery Embolization 10/2019 - 08/2018
2	Renal Dialysis (Hemodialysis) 01/2019 - 02/2016